Nedaplatin
Records for this ingredient, by country (identity only).
ATC L01XA · 2 markets · 21 records
CN 18 records · 4 shown of 4
JP 3 records · 3 shown of 3
- 100 mg per mL / per unit basis not statedinjectionアクプラ静注用100mg
- 50 mg per mL / per unit basis not statedinjectionアクプラ静注用100mg
- 10 mg per mL / per unit basis not statedinjectionアクプラ静注用100mg
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | CN | JP |
|---|---|---|
| 100 mgRecorded as: 0.1 g per mL / per unit basis not stated cannot compare injection | 奥先达奈达铂 泉铂奈达铂 鲁贝奈达铂 | アクプラ静注用100mg |
| 50 mg per mL / per unit basis not stated cannot compare injection | 奥先达奈达铂 泉铂奈达铂 鲁贝奈达铂 | アクプラ静注用100mg |
| 10 mg per mL / per unit basis not stated cannot compare injection | 奥先达奈达铂 捷佰舒奈达铂 鲁贝奈达铂 | アクプラ静注用100mg |
| 20 mg per mL / per unit basis not stated cannot compare injection | 奥先达奈达铂 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.